meglumine and Diabetic Glomerulosclerosis

meglumine has been researched along with Diabetic Glomerulosclerosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bravo-Nuevo, A; Huang, M; Kappler, F; Laury-Kleintop, L; Marcy, A; Mulgrew, J; Prendergast, GC; Reichman, M; Tobia, A	1
Bakris, GL; Flynn, C	1

Reviews

1 review(s) available for meglumine and Diabetic Glomerulosclerosis

Article	Year
Noninsulin glucose-lowering agents for the treatment of patients on dialysis. Nature reviews. Nephrology, 2013, Volume: 9, Issue:3 Topics: Adamantane; Biguanides; Diabetic Nephropathies; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Glucagon-Like Peptides; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Linagliptin; Meglumine; Metformin; Nitriles; Piperidines; Purines; Pyrazines; Pyrrolidines; Quinazolines; Renal Dialysis; Renal Insufficiency, Chronic; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Triazoles; Uracil; Vildagliptin	2013

Article

Year

Noninsulin glucose-lowering agents for the treatment of patients on dialysis.

Nature reviews. Nephrology, 2013, Volume: 9, Issue:3

Topics: Adamantane; Biguanides; Diabetic Nephropathies; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Glucagon-Like Peptides; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Linagliptin; Meglumine; Metformin; Nitriles; Piperidines; Purines; Pyrazines; Pyrrolidines; Quinazolines; Renal Dialysis; Renal Insufficiency, Chronic; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Triazoles; Uracil; Vildagliptin

2013

Other Studies

1 other study(ies) available for meglumine and Diabetic Glomerulosclerosis

Article	Year
Meglumine exerts protective effects against features of metabolic syndrome and type II diabetes. PloS one, 2014, Volume: 9, Issue:2 Topics: Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Female; Meglumine; Metabolic Syndrome; Mice; Muscle, Skeletal; Myoblasts; Organ Size; Protective Agents; Protein Serine-Threonine Kinases; Triglycerides	2014

Article

Year

Meglumine exerts protective effects against features of metabolic syndrome and type II diabetes.

PloS one, 2014, Volume: 9, Issue:2

Topics: Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Female; Meglumine; Metabolic Syndrome; Mice; Muscle, Skeletal; Myoblasts; Organ Size; Protective Agents; Protein Serine-Threonine Kinases; Triglycerides

2014